-
公开(公告)号：US20240277976A1
公开(公告)日：2024-08-22
申请号：US18644498
申请日：2024-04-24
申请人： Lixiao Wang , Neurotronic, Inc.
发明人： Lixiao Wang , John J. Chen , Yongxing Zhang
IPC分类号： A61M25/10 , A61B18/00 , A61B18/06 , A61K31/045 , A61M5/00 , A61M5/142 , A61M5/172 , A61M29/02
CPC分类号： A61M25/1002 , A61B18/06 , A61K31/045 , A61M5/007 , A61M5/142 , A61M5/172 , A61M25/1011 , A61M29/02 , A61B2018/00577 , A61M2025/105 , A61M2025/1052 , A61M2202/02
摘要： Embodiments of the present invention provide a device and a method for treating at least one of hypertension, pulmonary arteries, diabetes, obesity, heart failure, end-stage renal disease, digestive disease, urological disease, cancers, tumors, pain, asthma or chronic obstructive pulmonary disease by delivering an effective amount of a formulation to a tissue. In embodiments of the present invention, the formulation may include at least one of a gas, a vapor, a liquid, a solution, an emulsion, or a suspensions of one or more ingredients. In embodiments of the present invention, amounts of the formulation and/or energy are effective to injure or damage tissue, nerves, and nerve endings in order to relieve disease symptoms.
-
公开(公告)号：US20200016379A1
公开(公告)日：2020-01-16
申请号：US16563235
申请日：2019-09-06
申请人： Neurotronic, Inc.
发明人： Lixiao Wang , John J. Chen , Yongxing Zhang
摘要： Embodiments of the present invention provide a device and a method for treating at least one of hypertension, pulmonary arteries, diabetes, obesity, heart failure, end-stage renal disease, digestive disease, urological disease, cancers, tumors, pain, asthma or chronic obstructive pulmonary disease by delivering an effective amount of a formulation to a tissue. In embodiments of the present invention, the formulation may include at least one of a gas, a vapor, a liquid, a solution, an emulsion, or a suspensions of one or more ingredients. In embodiments of the present invention, amounts of the formulation and/or energy are effective to injure or damage tissue, nerves, and nerve endings in order to relieve disease symptoms.
-
公开(公告)号：US20200009355A1
公开(公告)日：2020-01-09
申请号：US16563213
申请日：2019-09-06
申请人： Neurotronic, Inc.
发明人： Lixiao Wang , John J. Chen , Yongxing Zhang
摘要： Embodiments of the present invention provide a device and a method for treating at least one of hypertension, pulmonary arteries, diabetes, obesity, heart failure, end-stage renal disease, digestive disease, urological disease, cancers, tumors, pain, asthma or chronic obstructive pulmonary disease by delivering an effective amount of a formulation to a tissue. In embodiments of the present invention, the formulation may include at least one of a gas, a vapor, a liquid, a solution, an emulsion, or a suspensions of one or more ingredients. In embodiments of the present invention, amounts of the formulation and/or energy are effective to injure or damage tissue, nerves, and nerve endings in order to relieve disease symptoms.
-
公开(公告)号：US20190274687A1
公开(公告)日：2019-09-12
申请号：US16334813
申请日：2017-09-20
申请人： Neurotronic, Inc.
发明人： Lixiao Wang , John J. Chen , Yongxing Zhang , Craig C. Belton , Shannon R. Stroud , Richard Cornelius , Scott Naisbitt
IPC分类号： A61B17/11
摘要： Embodiments of the present invention provide a magnetic anastomosis device (MAD), a delivery catheter for the MAD, and a method for treating at least one of diabetes, obesity, digestive disease, and non-alcoholic fatty liver disease. In embodiments of the present invention, a pair of the MADs are delivered in body lumen by endoscopic and/or laparoscopic techniques. An anastomosis between two adjacent body lumens is formed by compression of the pair of MADs followed by necrosis and regeneration of the lumen tissue. The bodily fluids are then redirected through the formed anastomosis to relieve disease symptoms.
-
公开(公告)号：US12005207B2
公开(公告)日：2024-06-11
申请号：US16986717
申请日：2020-08-06
申请人： Neurotronic, Inc.
发明人： Lixiao Wang , John J. Chen , Yongxing Zhang
IPC分类号： A61M25/10 , A61B18/06 , A61K31/045 , A61M5/00 , A61M5/142 , A61M5/172 , A61M29/02 , A61B18/00
CPC分类号： A61M25/1002 , A61B18/06 , A61K31/045 , A61M5/007 , A61M5/142 , A61M5/172 , A61M25/1011 , A61M29/02 , A61B2018/00577 , A61M2025/105 , A61M2025/1052 , A61M2202/02
摘要： Embodiments of the present invention provide a device and a method for treating at least one of hypertension, pulmonary arteries, diabetes, obesity, heart failure, end-stage renal disease, digestive disease, urological disease, cancers, tumors, pain, asthma or chronic obstructive pulmonary disease by delivering an effective amount of a formulation to a tissue. In embodiments of the present invention, the formulation may include at least one of a gas, a vapor, a liquid, a solution, an emulsion, or a suspensions of one or more ingredients. In embodiments of the present invention, amounts of the formulation and/or energy are effective to injure or damage tissue, nerves, and nerve endings in order to relieve disease symptoms.
-
公开(公告)号：US20220233827A1
公开(公告)日：2022-07-28
申请号：US17719032
申请日：2022-04-12
申请人： Neurotronic, Inc.
发明人： Lixiao Wang , John J. Chen , Yongxing Zhang
摘要： Embodiments of the present invention provide a device and a method for treating at least one of hypertension, pulmonary arteries, diabetes, obesity, heart failure, end-stage renal disease, digestive disease, urological disease, cancers, tumors, pain, asthma or chronic obstructive pulmonary disease by delivering an effective amount of a formulation to a tissue. In embodiments of the present invention, the formulation may include at least one of a gas, a vapor, a liquid, a solution, an emulsion, or a suspensions of one or more ingredients. In embodiments of the present invention, amounts of the formulation and/or energy are effective to injure or damage tissue, nerves, and nerve endings in order to relieve disease symptoms.
-
公开(公告)号：US20240277977A1
公开(公告)日：2024-08-22
申请号：US18644542
申请日：2024-04-24
申请人： Neurotronic, Inc.
发明人： Lixiao Wang , John J. Chen , Yongxing Zhang
IPC分类号： A61M25/10 , A61B18/00 , A61B18/06 , A61K31/045 , A61M5/00 , A61M5/142 , A61M5/172 , A61M29/02
CPC分类号： A61M25/1002 , A61B18/06 , A61K31/045 , A61M5/007 , A61M5/142 , A61M5/172 , A61M25/1011 , A61M29/02 , A61B2018/00577 , A61M2025/105 , A61M2025/1052 , A61M2202/02
摘要： Embodiments of the present invention provide a device and a method for treating at least one of hypertension, pulmonary arteries, diabetes, obesity, heart failure, end-stage renal disease, digestive disease, urological disease, cancers, tumors, pain, asthma or chronic obstructive pulmonary disease by delivering an effective amount of a formulation to a tissue. In embodiments of the present invention, the formulation may include at least one of a gas, a vapor, a liquid, a solution, an emulsion, or a suspension of one or more ingredients. In embodiments of the present invention, amounts of the formulation and/or energy are effective to injure or damage tissue, nerves, and nerve endings in order to relieve disease symptoms.
-
公开(公告)号：US11648378B2
公开(公告)日：2023-05-16
申请号：US16563213
申请日：2019-09-06
申请人： Neurotronic, Inc.
发明人： Lixiao Wang , John J. Chen , Yongxing Zhang
IPC分类号： A61M25/10 , A61M29/02 , A61M5/00 , A61M5/142 , A61M5/172 , A61B18/06 , A61K31/045 , A61B18/00
CPC分类号： A61M25/1002 , A61B18/06 , A61K31/045 , A61M5/007 , A61M5/142 , A61M5/172 , A61M25/1011 , A61M29/02 , A61B2018/00577 , A61M2025/105 , A61M2025/1052 , A61M2202/02
摘要： Embodiments of the present invention provide a device and a method for treating at least one of hypertension, pulmonary arteries, diabetes, obesity, heart failure, end-stage renal disease, digestive disease, urological disease, cancers, tumors, pain, asthma or chronic obstructive pulmonary disease by delivering an effective amount of a formulation to a tissue. In embodiments of the present invention, the formulation may include at least one of a gas, a vapor, a liquid, a solution, an emulsion, or a suspensions of one or more ingredients. In embodiments of the present invention, amounts of the formulation and/or energy are effective to injure or damage tissue, nerves, and nerve endings in order to relieve disease symptoms.
-
公开(公告)号：US10286191B2
公开(公告)日：2019-05-14
申请号：US15521973
申请日：2015-10-30
申请人： Neurotronic, Inc.
发明人： Lixiao Wang , John J. Chen , Yongxing Zhang
IPC分类号： A61M25/10 , A61M5/00 , A61M5/142 , A61M5/172 , A61M29/02 , A61B18/06 , A61K31/045 , A61B18/00
摘要： Embodiments of the present invention provide a device and a method for treating at least one of hypertension, pulmonary arteries, diabetes, obesity, heart failure, end-stage renal disease, digestive disease, urological disease, cancers, tumors, pain, asthma or chronic obstructive pulmonary disease by delivering an effective amount of a formulation to a tissue, In embodiments of the present invention, the formulation may include at least one of a gas, a vapor, a liquid, a solution, an emulsion, or a suspensions of one or more ingredients. In embodiments of the present invention, amounts of the formulation and/or energy are effective to injure or damage tissue, nerves, and nerve endings in order to relieve disease symptoms.
-
公开(公告)号：US11517725B2
公开(公告)日：2022-12-06
申请号：US16563235
申请日：2019-09-06
申请人： Neurotronic, Inc.
发明人： Lixiao Wang , John J. Chen , Yongxing Zhang
IPC分类号： A61M25/10 , A61M29/02 , A61M5/00 , A61M5/142 , A61M5/172 , A61B18/06 , A61K31/045 , A61B18/00
摘要： Embodiments of the present invention provide a device and a method for treating at least one of hypertension, pulmonary arteries, diabetes, obesity, heart failure, end-stage renal disease, digestive disease, urological disease, cancers, tumors, pain, asthma or chronic obstructive pulmonary disease by delivering an effective amount of a formulation to a tissue. In embodiments of the present invention, the formulation may include at least one of a gas, a vapor, a liquid, a solution, an emulsion, or a suspensions of one or more ingredients. In embodiments of the present invention, amounts of the formulation and/or energy are effective to injure or damage tissue, nerves, and nerve endings in order to relieve disease symptoms.
-
-
-
-
-
-
-
-
-
搜索结果
13 条记录 (耗时 0.017 秒)
